Autres langues Eli Lilly and Company Euronext Paris

Actions

LLY

US5324571083

Temps réel Euronext Paris Autres places de cotation 16:05:35 29/10/2019			Varia. 5j.	Varia. 1 janv.
98 ^EUR	-1,01%		-.--%	+2,08%

04:24	ELI LILLY AND COMPANY : Jefferies & Co. optimiste sur le dossier	ZM
23/05	Le bric-à-brac de Zonebourse : ETF amaigrissants, Europlasma et revanche d'Apple

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	16:29
Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars	16:22
Eli Lilly and : 2015 Global Health Programs Report	15:50
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	15:31
ETFs para adelgazar, y la revancha de Apple	23/05
Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln	23/05
Radar Therapeutics announced that it has received $13.4 million in funding from NFX Capital Management, LLC, Eli Lilly and Company, Biovision Ventures, KDT Ventures LLC, Pear Ventures Management, LLC, Bevc Management, Llc, and other investors	23/05
Swiss Equities Tumble as UK Inflation Data Dampens June Rate Cut Hopes	22/05
Eli Lilly Reports Positive Trial Results for Crohn's Disease Treatment	22/05
China Grants Green Light to Eli Lilly's Diabetes Treatment	22/05
Eli Lilly Wins Chinese Approval for Diabetes Drug	22/05
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro	22/05
Health Care Up as Eli Lilly Hits Record High - Health Care Roundup	21/05
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024	21/05
Two US asset managers launch weight-loss ETFs	21/05
Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson...	21/05
Eli Lilly : essai concluant dans la maladie de Crohn	21/05
Central bankers try to reason with investors	21/05
Sector Update: Health Care Stocks Steady Premarket Tuesday	21/05
Eli Lilly and Company's Phase 3 Study of Mirikizumab to Treat Crohn's Disease Achieves 'Meaningful Improvements'	21/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

David Ricks, PDG d'Eli Lilly : Un marche de plus d'un milliard de personnes

Le 12 mars 2024 à 19:47